Oncorus

OverviewSuggest Edit

Oncorus is developing potent oncolytic immunotherapies for cancer. Oncorus was founded by well-known biotechnology entrepreneurs and is backed by MPM Capital. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.
TypePrivate
Founded2015
HQCambridge, USMap
Websiteoncorus.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Mar 2020)50(+5%)

Key People/Management at Oncorus

Christophe Quéva

Christophe Quéva

Chief Scientific Officer
Mitchell H. Finer

Mitchell H. Finer

Executive Chairman
Luke Evnin

Luke Evnin

Director
John McCabe

John McCabe

Chief Financial Officer
Briggs W. Morrison

Briggs W. Morrison

Director
Lorena Lerner

Lorena Lerner

Vice President, Molecular Biology
Show more

Oncorus Office Locations

Oncorus has an office in Cambridge
Cambridge, US (HQ)
50 Hampshire St #401
Show all (1)

Oncorus Financials and Metrics

Summary Metrics

Founding Date

2015

Oncorus total Funding

$141.5 m

Oncorus latest funding size

$79.50 m

Time since last funding

8 months ago

Oncorus investors

Shinhan Private Equity, MPM Capital, Astellas Venture Management, Celgene, Perceptive Advisors, IMM Investment, Deerfield, Deerfield Management, Long March Investment Fund, Arkin Bio Ventures, Excelyrate Capital, SunStates Fund, Cowen Healthcare Investments, Surveyor Capital, UBS Oncology Impact Fund, UTC Investment Co., Sphera Funds, SV Investment Partners, Quad Asset Management, Arkin Bioventures, Celgene and Astellas Venture Management
Oncorus's latest funding round in August 2019 was reported to be $79.5 m. In total, Oncorus has raised $141.5 m
Show all financial metrics

Oncorus Online and Social Media Presence

Oncorus's Trends

Embed Graph

Oncorus News and Updates

August 21, 2019

Oncorus scores $79.5 mln Series B

Cambridge, Massachusetts-based Oncorus Inc, an oncolytic virus company, has raised $79.5 million in Series B financing. Cowen Healthcare Investments and Perceptive Advisors led the round.

 Oncorus Frequently Asked Questions

  • When was Oncorus founded?

    Oncorus was founded in 2015.

  • Who are Oncorus key executives?

    Oncorus's key executives are Christophe Quéva, Mitchell H. Finer and Luke Evnin.

  • How many employees does Oncorus have?

    Oncorus has 50 employees.

  • Who are Oncorus competitors?

    Competitors of Oncorus include Clementia Pharmaceuticals, DBV Technologies and Synthace.

  • Where is Oncorus headquarters?

    Oncorus headquarters is located at 50 Hampshire St #401, Cambridge.

  • Where are Oncorus offices?

    Oncorus has an office in Cambridge.

  • How many offices does Oncorus have?

    Oncorus has 1 office.